Cdymax Pharma has been slapped with a warning letter from the FDA outlining two observations against the Bangalore, India-based API maker, both linked to testing shortfalls. The letter comes in ...
After a testing lab in France was caught using unvalidated methods on some drug testing for clients, it told the FDA it had a solution. It would simply inform customers on their certificates of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback